Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
InoCure logo — InoCure brings next-generation nanotechnologies to you! #na...

InoCure

InoCure brings next-generation nanotechnologies to you! #nanofibers #electrospinning #facemask #covid19

Founded 2015 Czech Republic Czech Republic 3 employees Grant Total: $50.00K Biotechnology, Health Care +1

General Information

Company Name InoCure
Founded Year 2015
Location Czech Republic Czech Republic +1
Employees 3
Industries Biotechnology, Health Care, Life Sciences
Funding Stage Grant
Social

Get notified when InoCure moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About InoCure

InoCure is a biotechnology startup based in the Czech Republic, founded in 2015. The company specializes in providing advanced 3D cell culture scaffolds for drug screening and reducing animal testing. Their slogan "InoCure provides 3D cell culture scaffolds for drug screening and reducing animal testing. Mixed B2B and B2B2B business models" encapsulates their core focus. InoCure aims to enhance the reliability of cell culture outcomes and improve the efficiency of drug screening in the early stages while minimizing animal usage in toxicological research. InoCure's target audience includes all labs that utilize cells in their pipelines. The company operates using both mixed B2B and B2B2B business models. Their last recorded investment was a $50.00K Grant investment on 01 January 2016, with no specific information about the investors. The industries InoCure operates in are Biotechnology and Health Care. Overall, InoCure's innovative approach to enhancing cell culture outcomes and reducing animal testing in drug screening demonstrates potential for growth and positive impact within the biotechnology and healthcare industries.

Taxonomy: 3D cell culture, drug screening, animal testing reduction, B2B2B, cell culture scaffolds, toxicological research, efficiency enhancement, early-stage drug screening, lab equipment, cell-based assays

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Grant •••••• - 01 Jan 2016

InoCure Alternatives & Competitors

InoCure vs
Lena Biosciences
Lena Biosciences United States

3D Cell Culture & Perfused-Organ-Panel MPS Technology

Grant
4 employees
Biotechnology, Life Sciences
InoCure vs
CytoNiche
CytoNiche

Pioneering 3D micro-organization engineering for advanced stem cell solutions, inspired by Tsinghua...

Grant
51-200 employees
Biotechnology, Health Care
InoCure vs
InvivoSciences® Inc.
InvivoSciences® Inc. United States

Discovery with Human touch

Non Equity Assistance
4 employees
Biotechnology, Health Care

FAQ About InoCure

InoCure brings next-generation nanotechnologies to you! #nanofibers #electrospinning #facemask #covid19
InoCure was founded in 2015.
InoCure is headquartered in Czech Republic.
InoCure operates in the following industries: Biotechnology, Health Care, Life Sciences.
InoCure has approximately 3 employees.
InoCure has completed 1 funding round, raising a total of $50.00K. The latest funding stage is Grant.
Top alternatives and competitors to InoCure include Lena Biosciences, CytoNiche, InvivoSciences® Inc., Ananda Devices, inscreenex GmbH. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
InoCure and Lena Biosciences are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors InoCure and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes